Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,089,003 | 1,282,078 | 1,478,051 | 1,204,900 | 1,186,281 |
| Marketable Securities | 1,753,499 | 1,086,595 | 673,946 | 640,500 | 675,065 |
| Receivables | 1,327,780 | 1,310,821 | 1,389,995 | 1,292,400 | 1,091,232 |
| Inventories | 918,921 | 865,738 | 825,349 | 804,000 | 753,063 |
| Other current assets | 1,181,670 | 1,073,753 | 891,555 | 593,200 | 666,470 |
| TOTAL | $9,270,873 | $5,618,985 | $5,258,896 | $4,535,000 | $4,372,111 |
| Non-Current Assets | |||||
| PPE Net | 2,027,821 | 1,837,670 | 1,739,628 | 1,765,700 | 1,724,129 |
| Investments And Advances | 2,839,575 | 2,853,384 | 2,017,955 | 2,225,300 | 1,936,944 |
| Intangibles | 6,590,099 | 6,449,132 | 6,202,975 | 5,788,700 | 5,670,958 |
| Other Non-Current Assets | 5 | 4 | 1 | 0 | 0 |
| TOTAL | $11,457,500 | $11,140,190 | $9,960,559 | $9,779,700 | $9,332,031 |
| Total Assets | $20,728,370 | $16,759,170 | $15,219,450 | $14,314,700 | $13,704,140 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 251,228 | 282,702 | 236,128 | 229,200 | 233,629 |
| Accrued Expenses | 1,918,897 | 1,812,099 | 1,384,774 | 1,817,700 | 1,544,160 |
| TOTAL | $2,633,968 | $2,555,832 | $1,946,231 | $2,218,100 | $1,940,647 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,529,275 | 576,207 | 580,672 | 580,300 | 583,977 |
| Other Non-Current Liabilities | 807,521 | 918,231 | 894,929 | 650,960 | 659,014 |
| TOTAL | $7,527,457 | $1,630,341 | $1,603,765 | $1,282,600 | $1,332,610 |
| Total Liabilities | $10,161,420 | $4,186,173 | $3,549,996 | $3,500,700 | $3,273,257 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 222,903 | 235,169 | 235,230 | 234,615 | 236,155 |
| Common Shares | 124 | 129 | 129 | 100 | 129 |
| Retained earnings | 11,999,360 | 11,033,740 | 10,106,460 | 9,283,900 | 8,400,455 |
| Other shareholders' equity | -162,917 | -100,312 | -67,555 | -54,200 | -34,711 |
| TOTAL | $10,566,940 | $12,573,000 | $11,669,460 | $10,814,000 | $10,430,880 |
| Total Liabilities And Equity | $20,728,360 | $16,759,173 | $15,219,456 | $14,314,700 | $13,704,137 |